GlassScriptPhysician profile
Albert J Marano
NPI 1336290311
$145,271.13
in general payments reported to CMS, 2019-2025
82 companies · $19K in 2025
The $19K reported for 2025 was more than what 92% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $18K · 2021: $33K · 2022: $25K · 2023: $9,960 · 2024: $16K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Honoraria: $2,625 · Education: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $22,709.75 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,900.00 |
| Honoraria | $2,625.00 |
| Education | $239.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $28,939.70 | 2020-2025 | Xcopri |
| Genentech USA, INC. | $20,067.88 | 2019-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Abbvie INC. | $19,901.03 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $12,978.57 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $8,462.81 | 2020-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $7,329.18 | 2022 | |
| Allergan, INC. | $4,952.51 | 2019-2022 | |
| Pfizer INC. | $4,590.90 | 2019-2025 | |
| Celgene Corporation | $4,204.45 | 2021-2025 | Zeposia |
| Lundbeck LLC | $2,467.24 | 2020-2025 | Vyepti, Rexulti |
| Biogen, INC. | $2,270.64 | 2019-2025 | Tysabri, Vumerity, Avonex |
| Teva Pharmaceuticals USA, INC. | $2,088.91 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Novartis Pharmaceuticals Corporation | $1,901.95 | 2019-2025 | |
| Emd Serono, INC. | $1,845.41 | 2020-2025 | Mavenclad, Mavenclad |
| Ucb, INC. | $1,811.65 | 2019-2025 | Briviact, Rystiggo, Zilbrysq |
Show all 82 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,400.84 | 2019-2025 | Uplizna, Aimovig |
| Neurocrine Biosciences, INC. | $1,365.10 | 2019-2025 | Ingrezza, Ongentys |
| Neurelis, INC. | $1,205.18 | 2020-2025 | Valtoco |
| Takeda Pharmaceuticals U.S.A., INC. | $1,176.54 | 2019-2025 | Trintellix |
| Eisai INC. | $1,126.92 | 2019-2025 | |
| Acadia Pharmaceuticals INC | $910.12 | 2019-2025 | Nuplazid |
| Mallinckrodt Hospital Products INC. | $727.10 | 2020-2025 | Acthar |
| Csl Behring | $716.92 | 2019-2025 | Hizentra |
| Kyowa Kirin, INC. | $700.28 | 2019-2025 | Nourianz |
| Axsome Therapeutics, INC. | $695.09 | 2022-2025 | Sunosi, Symbravo, Auvelity |
| Lilly USA, LLC | $667.77 | 2019-2025 | Kisunla, Emgality, Amyvid |
| Mdd US Operations, LLC | $565.02 | 2022-2025 | Gocovri, Apokyn, Gocovri |
| Jazz Pharmaceuticals INC. | $552.73 | 2019-2025 | |
| Acorda Therapeutics, INC | $522.48 | 2019-2023 | Inbrija |
| Xeris Pharmaceuticals, INC. | $489.10 | 2021-2025 | Keveyis |
| Sunovion Pharmaceuticals INC. | $487.99 | 2019-2020 | |
| Adamas Pharmaceuticals, INC. | $443.15 | 2019-2021 | |
| Catalyst Pharmaceuticals, INC. | $431.65 | 2023-2025 | Fycompa |
| Mallinckrodt Enterprises LLC | $413.74 | 2019 | |
| Alexion Pharmaceuticals, INC. | $405.99 | 2019-2023 | Ultomiris |
| Livanova USA, INC. | $398.95 | 2019-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Supernus Pharmaceuticals, INC. | $398.69 | 2019-2025 | Qelbree |
| Tg Therapeutics, INC. | $379.44 | 2023-2025 | |
| Amneal Pharmaceuticals LLC | $372.76 | 2019-2023 | Rytary, Lyvispah |
| Upsher-Smith Laboratories LLC | $356.96 | 2019-2023 | |
| Avadel Cns Pharmaceuticals, LLC | $354.89 | 2023-2024 | Lumryz |
| Harmony Biosciences LLC | $329.32 | 2020-2025 | |
| Otsuka America Pharmaceutical, INC. | $311.35 | 2023-2025 | Rexulti, Nuedexta |
| Avanir Pharmaceuticals, INC. | $297.14 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $291.00 | 2022-2023 | Ponvory |
| Grifols USA, LLC | $259.77 | 2019-2023 | Gamunex-C |
| Merz North America, INC. | $216.36 | 2019 | |
| Horizon Therapeutics Plc | $188.45 | 2021-2023 | Uplizna |
| Genzyme Corporation | $182.68 | 2019-2025 | |
| Assertio Therapeutics, INC. | $177.40 | 2019-2020 | |
| Amylyx Pharmaceuticals, INC. | $172.96 | 2023-2024 | Relyvrio |
| Vanda Pharmaceuticals INC. | $165.63 | 2024-2025 | Ponvory |
| Ge Healthcare | $142.17 | 2020-2023 | |
| Shire North American Group INC | $138.16 | 2019 | |
| Arbor Pharmaceuticals, INC. | $123.14 | 2019-2021 | |
| Akcea Therapeutics, INC. | $116.73 | 2019-2021 | |
| Ipsen Biopharmaceuticals, INC | $107.31 | 2022-2025 | Dysport |
| Avion Pharmaceuticals | $101.46 | 2022-2023 | Dhivy |
| Strongbridge US INC. | $88.02 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $71.43 | 2024 | Aptiom |
| Promius Pharma LLC | $68.41 | 2019 | |
| Almatica Pharma LLC | $63.31 | 2021 | |
| Tanabe Pharma America, INC. | $58.36 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $54.10 | 2022-2023 | Evusheld |
| Genentech, INC. | $49.10 | 2022-2023 | Ocrevus |
| Alnylam Pharmaceuticals INC. | $46.63 | 2019 | |
| Currax Pharmaceuticals LLC | $45.18 | 2020-2024 | Contrave, Onzetra Xsail |
| Medtronic USA, INC. | $43.74 | 2019 | |
| Janssen Biotech, INC. | $42.50 | 2019-2025 | |
| Tonix Medicines, INC. | $24.39 | 2025 | Tonmya |
| Inspire Medical Systems, INC. | $24.24 | 2025 | Inspire |
| Bausch Health US, LLC | $23.41 | 2025 | Wellbutrin |
| Globus Medical, INC. | $22.75 | 2025 | Senza |
| Argenx US, INC. | $22.59 | 2022 | |
| Grt US Holding, INC. | $22.26 | 2022 | |
| Banner Life Sciences, LLC | $18.91 | 2022 | |
| Azurity Pharmaceuticals, INC. | $16.58 | 2023 | Horizant |
| Alfasigma USA, INC. | $16.04 | 2020 | |
| Merz Pharmaceuticals, LLC | $15.91 | 2022 | |
| Zyla Life Sciences, INC. | $12.88 | 2019 | |
| Ani Pharmaceuticals, INC. | $12.79 | 2022 | |
| Life Molecular Imaging LTD | $8.34 | 2024 | Neuraceq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Marano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.